BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31094909)

  • 1. Isavuconazole Treatment of Cerebral and Pulmonary Aspergillosis in a Pediatric Patient With Acute Lymphoblastic Leukemia: Case Report and Review of Literature.
    De Leonardis F; Novielli C; Giannico B; Mariggiò MA; Castagnola E; Santoro N
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e469-e471. PubMed ID: 31094909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
    Andes DR; Ghannoum MA; Mukherjee PK; Kovanda LL; Lu Q; Jones ME; Santerre Henriksen A; Lademacher C; Hope WW
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graded isavuconazole introduction in a patient with voriconazole allergy.
    Morales MK; Harris C; Shoham S
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28851131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment of Chronic Pulmonary Aspergillosis With Isavuconazole.
    Guillen Vera D; Ruiz Ruigómez M; García Moguel I; Morales Ruiz R; Corbella L; Fernández Rodríguez C
    J Investig Allergol Clin Immunol; 2019; 29(6):459-460. PubMed ID: 31172952
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
    Björkholm M; Kalin M; Grane P; Celsing F
    Infection; 2012 Feb; 40(1):81-5. PubMed ID: 21779887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
    Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
    Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole.
    Machetti M; Zotti M; Veroni L; Mordini N; Van Lint MT; Bacigalupo A; Paola D; Viscoli C
    Transpl Infect Dis; 2000 Sep; 2(3):140-4. PubMed ID: 11429025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients.
    Barg AA; Malkiel S; Bartuv M; Greenberg G; Toren A; Keller N
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27281. PubMed ID: 29932282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
    Okamoto T; Koh K; Takita J; Furuya A; Kato M; Ida K
    Pediatr Int; 2010 Feb; 52(1):137-41. PubMed ID: 20158658
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient.
    Assaf A; Faure E; Sermet K; Loridant S; Leroy J; Goeminne C; Dozier A; Chopin MC; Panaget S; Faure K; Vuotto F
    Transpl Infect Dis; 2020 Oct; 22(5):e13313. PubMed ID: 32386273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of orbitocerebral aspergillosis during combination treatment with voriconazole and amphotericin plus adjunctive cytokine therapy.
    Bethell D; Hall G; Goodman TR; Klein N; Pollard AJ
    J Pediatr Hematol Oncol; 2004 May; 26(5):304-7. PubMed ID: 15111783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous isavuconazole can be administered 5 days-a-week. A possibility suggested by a real-life observation.
    Castagnola E; Mesini A; Saffioti C; Barco S; Bandettini R; Dallorso S; Carrega G; Miano M; Palmisani E; Dufour C
    J Chemother; 2020 Jul; 32(4):217-218. PubMed ID: 32364049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
    Ullmann AJ; Aguado JM; Arikan-Akdagli S; Denning DW; Groll AH; Lagrou K; Lass-Flörl C; Lewis RE; Munoz P; Verweij PE; Warris A; Ader F; Akova M; Arendrup MC; Barnes RA; Beigelman-Aubry C; Blot S; Bouza E; Brüggemann RJM; Buchheidt D; Cadranel J; Castagnola E; Chakrabarti A; Cuenca-Estrella M; Dimopoulos G; Fortun J; Gangneux JP; Garbino J; Heinz WJ; Herbrecht R; Heussel CP; Kibbler CC; Klimko N; Kullberg BJ; Lange C; Lehrnbecher T; Löffler J; Lortholary O; Maertens J; Marchetti O; Meis JF; Pagano L; Ribaud P; Richardson M; Roilides E; Ruhnke M; Sanguinetti M; Sheppard DC; Sinkó J; Skiada A; Vehreschild MJGT; Viscoli C; Cornely OA
    Clin Microbiol Infect; 2018 May; 24 Suppl 1():e1-e38. PubMed ID: 29544767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful antifungal combination therapy with voriconazole and caspofungin.
    Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
    Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients.
    Bellanger AP; Berceanu A; Scherer E; Desbrosses Y; Daguindau E; Rocchi S; Millon L
    Emerg Infect Dis; 2019 Sep; 25(9):1778-1779. PubMed ID: 31441760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated invasive aspergillosis in a patient with acute leukaemia.
    Gottfredsson M; Steingrímsdóttir H
    Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isavuconazole: Case Report and Pharmacokinetic Considerations.
    Marchesi F; Girmenia C; Goffredo BM; Salvatorelli E; Romano A; Mengarelli A; Minotti G; Menna P
    Chemotherapy; 2018; 63(5):253-256. PubMed ID: 30458443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of pulmonary aspergillosis.
    Kanj A; Abdallah N; Soubani AO
    Respir Med; 2018 Aug; 141():121-131. PubMed ID: 30053957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
    Sehgal IS; Dhooria S; Muthu V; Prasad KT; Agarwal R
    Expert Rev Respir Med; 2020 Jul; 14(7):715-727. PubMed ID: 32249630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
    Hoenigl M; Krause R
    Curr Pharm Des; 2013; 19(20):3648-68. PubMed ID: 23278539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.